Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,870 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New-generation drug-eluting stents reduce stent thrombosis and myocardial infarction: a propensity-score-adjusted analysis from the multicenter REAL registry (REgistro Regionale AngiopLastiche Dell'Emilia-Romagna).
Vignali L, Saia F, Belotti LM, Solinas E, Guastaroba P, Rubboli A, Manari A, Mehran R, Ardissino D, De Palma R. Vignali L, et al. Among authors: mehran r. Catheter Cardiovasc Interv. 2015 Apr;85(5):797-806. doi: 10.1002/ccd.25675. Epub 2014 Oct 14. Catheter Cardiovasc Interv. 2015. PMID: 25256440
Randomized, double-blind, multicenter study of the polymer-based 17-beta estradiol-eluting stent for treatment of native coronary artery lesions: six-month results of the ETHOS I trial.
Abizaid A, Chaves AJ, Leon MB, Hauptmann K, Mehran R, Lansky AJ, Baumbach W, Shankar H, Muller R, Feres F, Sousa AG, Sousa JE, Grube E. Abizaid A, et al. Among authors: mehran r. Catheter Cardiovasc Interv. 2007 Nov 1;70(5):654-60. doi: 10.1002/ccd.21210. Catheter Cardiovasc Interv. 2007. PMID: 17932898 Clinical Trial.
Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysis.
Sano K, Mintz GS, Carlier SG, Solinas E, Costa Jde R Jr, Qian J, Missel E, Shan S, Franklin-Bond T, Boland P, Weisz G, Moussa I, Dangas G, Mehran R, Lansky AJ, Kreps E, Collins M, Stone GW, Moses JW, Leon MB. Sano K, et al. Among authors: mehran r. J Invasive Cardiol. 2007 Nov;19(11):464-8. J Invasive Cardiol. 2007. PMID: 17986721 Clinical Trial.
Gender-specific outcomes after sirolimus-eluting stent implantation.
Solinas E, Nikolsky E, Lansky AJ, Kirtane AJ, Morice MC, Popma JJ, Schofer J, Schampaert E, Pucelikova T, Aoki J, Fahy M, Dangas GD, Moses JW, Cutlip DE, Leon MB, Mehran R. Solinas E, et al. Among authors: mehran r. J Am Coll Cardiol. 2007 Nov 27;50(22):2111-6. doi: 10.1016/j.jacc.2007.06.056. Epub 2007 Nov 13. J Am Coll Cardiol. 2007. PMID: 18036446 Free article. Clinical Trial.
Comparison of the effects of pretreatment with tirofiban, clopidogrel or both on the inhibition of platelet aggregation and activation in patients with acute coronary syndromes.
Solinas E, Gobbi G, Dangas G, Mehran R, Fahy M, Ippolito L, Bolognesi MG, Ruenes R, Merlini PA, Ardissino D, Vitale M. Solinas E, et al. Among authors: mehran r. J Thromb Thrombolysis. 2009 Jan;27(1):36-43. doi: 10.1007/s11239-007-0174-x. Epub 2007 Nov 30. J Thromb Thrombolysis. 2009. PMID: 18049795 Clinical Trial.
Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents.
Nikolsky E, Holmes DR, Mehran R, Dangas G, Schampaert E, Morice MC, Schofer J, Sousa JE, Fahy M, Na Y, Donohoe DJ, Moses JW, Leon MB. Nikolsky E, et al. Among authors: mehran r. Catheter Cardiovasc Interv. 2008 Jun 1;71(7):896-906. doi: 10.1002/ccd.21548. Catheter Cardiovasc Interv. 2008. PMID: 18498145
Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention.
Solinas E, Dangas G, Kirtane AJ, Lansky AJ, Franklin-Bond T, Boland P, Syros G, Kim YH, Gupta A, Mintz G, Fahy M, Collins M, Kodali S, Stone GW, Moses JW, Leon MB, Mehran R. Solinas E, et al. Among authors: mehran r. Am J Cardiol. 2008 Aug 1;102(3):311-5. doi: 10.1016/j.amjcard.2008.03.060. Epub 2008 May 24. Am J Cardiol. 2008. PMID: 18638592
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trial.
Lansky AJ, Tsuchiya Y, Brener M, Mehran R, Cristea E, Pietras C, Grines CL, Cox DA, Garcia E, Tcheng JE, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Leon MB, Moses J, Stone GW. Lansky AJ, et al. Among authors: mehran r. Catheter Cardiovasc Interv. 2008 Dec 1;72(7):917-24. doi: 10.1002/ccd.21714. Catheter Cardiovasc Interv. 2008. PMID: 19016469
Real world safety and efficacy of the Janus Tacrolimus-Eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting STent (TEST) registry.
Tamburino C, Di Salvo ME, Capodanno D, Capranzano P, Parisi R, Mirabella F, Scardaci F, Ussia G, Galassi AR, Fiscella D, Mehran R, Dangas G. Tamburino C, et al. Among authors: mehran r. Catheter Cardiovasc Interv. 2009 Feb 1;73(2):243-8. doi: 10.1002/ccd.21750. Catheter Cardiovasc Interv. 2009. PMID: 19156896
1,870 results